COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,044 Articles (21,535 medRxiv, 7,509 bioRxiv)

Most recent first Previous |  Page 720: Articles 7191-7200  | Next

Increased household transmission and immune escape of the SARS-CoV-2 Omicron variant compared to the Delta variant: evidence from Norwegian contact tracing and vaccination data
Jalali, N., Brustad, H. K., Frigessi, A., MacDonald, E. A., Meijerink, H., Firuglio, S. L., Nygard, K. M., Ro, G. O. I., Madslien, E. H., de Blasio, B. F.
10.1101/2022.02.07.22270437 — Posted: 2022-02-08
Circulating polyunsaturated fatty acids and COVID-19: a prospective cohort study and Mendelian randomization analysis
Sun, Y., Chatterjee, R., Ronanki, A., Ye, K.
10.1101/2022.02.06.22270562 — Posted: 2022-02-08
Spatio-temporal epidemiology of SARS-CoV-2 virus lineages in Teesside, UK, in 2020: effects of social deprivation, weather and lockdown on lineage dynamics
Rushton, S., Moss, E., Baker, P., Bashton, M., dos Santos, R., O'Brien, S., Richards, Z., Sanderson, R., Yew, W., Young, G., Brooks, E., Smith, D.
10.1101/2022.02.05.22269279 — Posted: 2022-02-08
Acoustic Epidemiology in Pulmonary Tuberculosis & Covid19 leveraging Explainable AI/ML
pathri, r., Jha, S., tandon, s., Gangashetty, S.
10.1101/2022.02.05.22269707 — Posted: 2022-02-08
Effectiveness of Covid-19 Vaccines against the SARS-COV-2-Delta (B.1.617.2) in China-A Real World Study
Ma, X., Han, J., Li, H., Liu, C.
10.1101/2022.02.07.22270490 — Posted: 2022-02-08
Validating saliva as a biological sample for cost-effective, rapid and routine screening for SARS-CoV-2
Ansil, B. R., George, C. E., Chandrasingh, S., Viswanathan, A., Thattai, M., Raghu, P., Devadiga, S., Harikumar, A. G., Harsha, P. K., Nair, I., Ramakrishnan, U., Mayor, S.
10.1101/2022.02.07.22269889 — Posted: 2022-02-08
Changes in the number of public health nurses employed in local governments in Japan during the Covid-19 pandemic: A cross-sectional study
Taira, K., Hosokawa, R., Shiomi, M.
10.1101/2022.02.06.22270346 — Posted: 2022-02-08
COVID-19 outbreaks in Australia during a period of high epidemic control, 2020
Hogarth, F. G., Nye, R., Pingault, N., Crouch, S., Coffey, C., Smith, K., Boyd, R., Kelaher, C., Reinten, T., Hewitt, M. C., Polkinghorne, B., Kirk, M.
10.1101/2022.02.07.22270575 — Posted: 2022-02-07
SARS-CoV-2 mRNA vaccination fails to elicit humoral and cellular immune responses in multiple sclerosis patients receiving fingolimod
Meyer-Arndt, L., Braun, J., Fauchere, F., Vanshylla, K., Loyal, L., Henze, L., Kruse, B., Dingeldey, M., Juerchott, K., Mangold, M., Maraj, A., Braginets, A., Boettcher, C., Nitsche, A., de la Rosa, K., Ratswohl, C., Sawitzki, B., Holenya, P., Reimer, U., Sander, L. E., Klein, F., Paul, F., Bellmann-Strobl, J., Thiel, A., Giesecke-Thiel, C.
10.1101/2022.02.06.22270550 — Posted: 2022-02-07
Estimating the risk reduction of isolation on COVID-19 non-household transmission and severe/critical illness in non-immune individuals: September to November 2021
Prosser, A., Helfer, B., Streiner, D. L.
10.1101/2022.02.05.22270453 — Posted: 2022-02-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).